Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Crexendo (CXDO) Research & Development (2016 - 2026)

Crexendo filings provide 15 years of Research & Development readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Research & Development fell 10.39% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.7 million, a 3.03% increase, with the full-year FY2025 number at $5.7 million, up 3.03% from a year prior.
  • Research & Development hit $1.3 million in Q4 2025 for Crexendo, down from $1.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.5 million in Q1 2025 to a low of $300000.0 in Q4 2021.
  • Median Research & Development over the past 5 years was $1.3 million (2023), compared with a mean of $1.1 million.
  • Biggest five-year swings in Research & Development: decreased 14.04% in 2021 and later skyrocketed 323.67% in 2022.
  • Crexendo's Research & Development stood at $300000.0 in 2021, then surged by 323.67% to $1.3 million in 2022, then decreased by 1.26% to $1.3 million in 2023, then rose by 19.68% to $1.5 million in 2024, then dropped by 10.39% to $1.3 million in 2025.
  • The last three reported values for Research & Development were $1.3 million (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.